The Role of Osteopontin in Respiratory Health and Disease
暂无分享,去创建一个
[1] C. Wang,et al. HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer , 2023, Cell death discovery.
[2] Hendra Gunosewoyo,et al. Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets , 2023, International journal of molecular sciences.
[3] L. Ferreira,et al. The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles , 2023, International journal of molecular sciences.
[4] J. Virchow,et al. Biologics and airway remodeling in severe asthma , 2022, Allergy.
[5] Teng-Fei Li,et al. Osteopontin and its downstream carcinogenic molecules: regulatory mechanisms and prognostic value in cancer progression. , 2022, Neoplasma.
[6] Wenlong Liu,et al. Osteopontin mediated eosinophils activation by group II innate lymphoid cells , 2022, The World Allergy Organization journal.
[7] R. Schermuly,et al. Clinical and Molecular Implications of Osteopontin in Heart Failure , 2022, Current issues in molecular biology.
[8] A. Brown,et al. Osteopontin/secreted phosphoprotein‐1 harnesses glial‐, immune‐, and neuronal cell ligand‐receptor interactions to sense and regulate acute and chronic neuroinflammation , 2022, Immunological reviews.
[9] C. Lange,et al. The Role of Osteopontin in Microglia Biology: Current Concepts and Future Perspectives , 2022, Biomedicines.
[10] S. Mou,et al. Comparison of CRP, Procalcitonin, Neutrophil Counts, Eosinophil Counts, sTREM-1, and OPN between Pneumonic and Nonpneumonic Exacerbations in COPD Patients , 2022, Canadian respiratory journal.
[11] Yaohong Wu,et al. Osteopontin in autoimmune disorders: current knowledge and future perspective , 2022, Inflammopharmacology.
[12] T. Ueland,et al. Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology , 2022, Platelets.
[13] S. Dietmann,et al. Identification of kidney injury released circulating osteopontin as causal agent of respiratory failure , 2022, Science advances.
[14] Wei‐Chien Huang,et al. Cigarette smoke-promoted increases in osteopontin expression attract mesenchymal stem cell recruitment and facilitate lung cancer metastasis , 2021, Journal of advanced research.
[15] C. Johnson,et al. COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males , 2021, Viruses.
[16] Christian S. Jensen,et al. COPD – do the right thing , 2021, BMC Family Practice.
[17] S. Ryter,et al. Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis. , 2021, Annual review of pathology.
[18] I. Sayeed,et al. Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: A pilot study , 2021, Experimental biology and medicine.
[19] T. Luedde,et al. Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19 , 2021, Journal of clinical medicine.
[20] T. Ohtsuki,et al. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[21] Yuanlin Song,et al. Regulatory roles of osteopontin in human lung cancer cell epithelial‐to‐mesenchymal transitions and responses , 2021, Clinical and translational medicine.
[22] N. Papadopoulos,et al. A Current Perspective of Allergic Asthma: From Mechanisms to Management. , 2021, Handbook of experimental pharmacology.
[23] M. Pirisi,et al. Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) , 2021, Pharmaceuticals.
[24] B. Mao,et al. High expression of SPP1 in patients with chronic obstructive pulmonary disease (COPD) is correlated with increased risk of lung cancer , 2021, FEBS open bio.
[25] A. Turner,et al. Small Airways Disease, Biomarkers and COPD: Where are We? , 2021, International journal of chronic obstructive pulmonary disease.
[26] Farhad Salari,et al. Determination of the transcriptional level of long non-coding RNA NEAT-1, downstream target microRNAs, and genes targeted by microRNAs in diabetic neuropathy patients. , 2021, Immunology letters.
[27] Mark G. Jones,et al. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development. , 2020, Pharmacology & therapeutics.
[28] H. Fan,et al. The association between osteopontin and tuberculosis: A systematic review and meta-analysis , 2020, PloS one.
[29] Yang Zhang,et al. Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer , 2020, Journal of Hematology & Oncology.
[30] M. Grant,et al. The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes , 2020, Cells.
[31] T. Gavrilova,et al. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes. , 2020, Paediatric respiratory reviews.
[32] T. Hirano,et al. How COVID-19 induces cytokine storm with high mortality , 2020, Inflammation and regeneration.
[33] Qian Zhang,et al. Prognostic significance of serum osteopontin levels in small cell lung cancer , 2020, BMC Pulmonary Medicine.
[34] S. Mandras,et al. Pulmonary Hypertension: A Brief Guide for Clinicians. , 2020, Mayo Clinic proceedings.
[35] W. Labaki,et al. Chronic Obstructive Pulmonary Disease , 2020, Annals of Internal Medicine.
[36] Anushka V. Devnikar,et al. A systemic review on tuberculosis. , 2020, The Indian journal of tuberculosis.
[37] Stefano Volpi,et al. On the Alert for Cytokine Storm: Immunopathology in COVID‐19 , 2020, Arthritis & rheumatology.
[38] I. Wakabayashi,et al. HDGF enhances VEGF-dependent angiogenesis and FGF-2 is a VEGF-independent angiogenic factor in non-small cell lung cancer , 2020, Oncology reports.
[39] X. Gui,et al. Prognostic Value of Serum Osteopontin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis , 2020, BioMed research international.
[40] Hae‐Sim Park,et al. Osteopontin contributes to late-onset asthma phenotypes in adult asthma patients , 2020, Experimental & Molecular Medicine.
[41] Chaowei Wang,et al. Osteopontin in Bone Metabolism and Bone Diseases , 2020, Medical science monitor : international medical journal of experimental and clinical research.
[42] J. Erjefält,et al. Author Correction: Osteopontin Expression in Small Airway Epithelium in Copd is Dependent on Differentiation and Confined to Subsets of Cells , 2020, Scientific Reports.
[43] Jing Huang,et al. OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase , 2019, Scientific Reports.
[44] J. Granton,et al. Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension , 2019, Respirology.
[45] Chien-Feng Li,et al. Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer , 2019, BMC Cancer.
[46] A. Lamort,et al. Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight , 2019, Cells.
[47] P. Benos,et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis , 2019, European Respiratory Journal.
[48] Hangdi Xu,et al. Association between osteopontin expression and asthma: a meta-analysis , 2019, The Journal of international medical research.
[49] G. Hasenfuss,et al. Potential Involvement of Osteopontin in Inflammatory and Fibrotic Processes in Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension , 2019, Thrombosis and Haemostasis.
[50] J. Ko,et al. Spectrum of Lung Adenocarcinoma. , 2019, Seminars in ultrasound, CT, and MR.
[51] K. Brown,et al. Idiopathic Pulmonary Fibrosis: Epidemiology, Diagnosis andOutcomes , 2019, The American journal of the medical sciences.
[52] Madhukar Pai,et al. Tuberculosis , 2019, The Lancet.
[53] M. Gutierrez,et al. Mycobacterium tuberculosis infection of host cells in space and time , 2019, FEMS microbiology reviews.
[54] Shengshou Hu,et al. Osteopontin plays important roles in pulmonary arterial hypertension induced by systemic‐to‐pulmonary shunt , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] Paul G. Williams,et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.
[56] G. Giovannoni,et al. Multiple sclerosis – a review , 2018, European journal of neurology.
[57] Hong Liu,et al. Secreted Phosphoprotein 1 Promotes the Development of Small Cell Lung Cancer Cells by Inhibiting Autophagy and Apoptosis , 2018, Pathology & Oncology Research.
[58] J. Kropski,et al. Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets. , 2018, Matrix biology : journal of the International Society for Matrix Biology.
[59] M. Gezmen-Karadag,et al. The multiple functions and mechanisms of osteopontin. , 2018, Clinical biochemistry.
[60] L. Palmberg,et al. Osteopontin protects against lung injury caused by extracellular histones , 2018, Mucosal Immunology.
[61] Y. Okamoto,et al. Amphiregulin‐Producing Pathogenic Memory T Helper 2 Cells Instruct Eosinophils to Secrete Osteopontin and Facilitate Airway Fibrosis , 2018, Immunity.
[62] Hailin Zhao,et al. The role of osteopontin in the progression of solid organ tumour , 2018, Cell Death & Disease.
[63] K. Kostikas,et al. Serum osteopontin in patients with lung cancer and chronic obstructive pulmonary disease: does the co-existence make the difference? , 2018, Journal of Thoracic Disease.
[64] Roy S. Herbst,et al. The biology and management of non-small cell lung cancer , 2018, Nature.
[65] N. Rezaei,et al. Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis , 2018, PloS one.
[66] Ran Wei,et al. Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer , 2017, International journal of biological sciences.
[67] S. Yolbaş,et al. Serum osteopontin and vitronectin levels in systemic sclerosis. , 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[68] A. Chiocchetti,et al. Osteopontin at the Crossroads of Inflammation and Tumor Progression , 2017, Mediators of inflammation.
[69] Mark G. Jones,et al. Idiopathic pulmonary fibrosis , 2017, The Lancet.
[70] J. Chataway,et al. Multiple sclerosis, a treatable disease , 2016, Clinical medicine.
[71] M. Ochani,et al. Neutralization of Osteopontin Ameliorates Acute Lung Injury Induced by Intestinal Ischemia-Reperfusion , 2016, Shock.
[72] J. Mims. Asthma: definitions and pathophysiology , 2015, International forum of allergy & rhinology.
[73] Juan Lin,et al. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer. , 2015, Cancer epidemiology.
[74] Jovilė Raudoniūtė,et al. Novel aspects of pathogenesis and regeneration mechanisms in COPD , 2015, International journal of chronic obstructive pulmonary disease.
[75] Yang Zhang,et al. Site-specific structural characterization of O-glycosylation and identification of phosphorylation sites of recombinant osteopontin. , 2015, Biochimica et biophysica acta.
[76] M. Seo,et al. Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN-γ-secreting T-cell Ratios in Bleomycin-treated Mice , 2015, Immune network.
[77] S. Sadiq,et al. Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status , 2014, Molecular Diagnosis & Therapy.
[78] Seung Hun Lee,et al. Increased plasma osteopontin in frequent exacerbator and acute exacerbation of COPD , 2014, The clinical respiratory journal.
[79] A. Godwin,et al. Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers. , 2014, Critical reviews in oncology/hematology.
[80] C. Shao,et al. An Osteopontin‐Integrin Interaction Plays a Critical Role in Directing Adipogenesis and Osteogenesis by Mesenchymal Stem Cells , 2014, Stem cells.
[81] H. Collard,et al. Epidemiology of idiopathic pulmonary fibrosis , 2013, Clinical epidemiology.
[82] K. Kostikas,et al. Increased levels of osteopontin in sputum supernatant in patients with COPD. , 2012, Chest.
[83] H. Katus,et al. Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension , 2012, European journal of clinical investigation.
[84] L. Tanoue,et al. Lung cancer: epidemiology, etiology, and prevention. , 2011, Clinics in chest medicine.
[85] G. Kwakkel,et al. Respiratory muscle training for multiple sclerosis. , 2011, The Cochrane database of systematic reviews.
[86] S. Konno,et al. Role of osteopontin, a multifunctional protein, in allergy and asthma , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[87] H. Haller,et al. Osteopontin in patients with idiopathic pulmonary hypertension. , 2011, Chest.
[88] J. Lötvall,et al. Osteopontin expression and relation to disease severity in human asthma , 2010, European Respiratory Journal.
[89] C. Roussos,et al. Osteopontin is upregulated in malignant and inflammatory pleural effusions , 2009, Respirology.
[90] K. Kostikas,et al. Global assessment of the COPD patient: time to look beyond FEV1? , 2009, Respiratory medicine.
[91] S. Xue,et al. Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning , 2009, Heart and Vessels.
[92] R. Breuer,et al. Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma. , 2009, American journal of respiratory cell and molecular biology.
[93] M. Tschöp,et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. , 2007, The Journal of clinical investigation.
[94] F. Levi-Schaffer,et al. Enhanced osteopontin expression in a murine model of allergen‐induced airway remodelling , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[95] D. Lin,et al. Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.
[96] S. Abe,et al. Circulating interleukin-18 and osteopontin are useful to evaluate disease activity in patients with tuberculosis. , 2005, Cytokine.
[97] M. Maeda,et al. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. , 2003, American journal of respiratory and critical care medicine.
[98] R. Young,et al. A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[99] Chunhua Xu. Prognostic signi cance of serum osteopontin levels in small-cell lung cancer , 2021 .
[100] L. Boulet. Airway remodeling in asthma: update on mechanisms and therapeutic approaches , 2018, Current opinion in pulmonary medicine.
[101] K. Rasche,et al. Asthma and COPD: Similarities and Differences in the Pathophysiology, Diagnosis and Therapy. , 2016, Advances in experimental medicine and biology.
[102] H. Olschewski,et al. [Pulmonary hypertension]. , 2012, Deutsche medizinische Wochenschrift.
[103] Z. Hoo,et al. Idiopathic pulmonary fibrosis , 2022 .